Star Lake Bioscience Co., Inc.Zhaoqing Guangdong (SHA:600866)
China · Delayed Price · Currency is CNY 4.250
-0.210 (-4.71%)
Aug 21, 2026, 3:00 PM CST
SHA:600866 Market Cap
SHA:600866 has a market cap or net worth of 7.06 billion as of August 21, 2026. Its market cap has decreased by -48.92% in one year.
Market Cap
7.06B
Enterprise Value
13.01B
Revenue
15.93B
Ranking
n/a
PE Ratio
33.08
Stock Price
4.25
ChartMarket Cap Chart
Since August 25, 2006, SHA:600866's market cap has increased from 1.16B to 7.06B, an increase of 507.65%. That is a compound annual growth rate of 9.44%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 21, 2026 | 7.06B | -38.85% |
| Dec 31, 2025 | 11.55B | 7.42% |
| Dec 31, 2024 | 10.75B | 38.84% |
| Dec 29, 2023 | 7.74B | -21.42% |
| Dec 30, 2022 | 9.85B | 113.65% |
| Dec 31, 2021 | 4.61B | 25.05% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Bio-Thera Solutions | 8.52B |
| Shanghai OPM Biosciences | 8.41B |
| Liaoning Chengda Biotechnology | 8.26B |
| Aurisco Pharmaceutical | 8.07B |
| Chengdu Easton Biopharmaceuticals | 7.87B |
| Innovita Biological Technology | 7.71B |
| Daan Gene | 7.62B |
| Jiangsu Aidea Pharmaceutical Group | 7.51B |